This is a Multipart Phase 1 Randomized, Double blind and Placebo controlled Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in healthy male and postmenopausal female volunteers.
Part A- approximately 76 (Approximately 8 sequential cohorts of 8 subjects per cohort)
Part B- Up to approximately, 32 healthy males or post-menopausal female subjects will be enrolled
Part C- Approximately 32 healthy male or postmenopausal female subjects (4 sequential cohorts of 8 subjects) will be enrolled
| Condition | Healthy Volunteer Study |
|---|---|
| Treatment | Matching Placebo, SCO-120 |
| Clinical Study Identifier | NCT04242953 |
| Sponsor | Sun Pharma Advanced Research Company Limited |
| Last Modified on | 2 June 2022 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.